|
|
Home  CMSC Online For CMSC Members Annual Meetings
|
Annual Meeting 2007 Highlights |
|
|
Diagnosing MS and Monitoring Disease Progression: Imaging, Antibodies, and Leukocytes
Click on this link to access the program http://www.m2usa.com/diagnosing_ms - Clinical and Laboratory Analysis: Immunopathology of Multiple Sclerosis
Mark Freedman, MD
Professor, Department of Medicine
Director, Multiple Sclerosis Research Unit
The Ottawa Hospital-General Campus
University of Ottawa
Ottawa, Ontario, Canada
- Radiological Imaging in the Diagnosis and Treatment of MS
Douglas L. Arnold, MD
Professor, Neurology and Neurosurgery
Montreal Neurological Institute
McGill University
Montreal, Quebec, Canada
- The Impact of Advances in Diagnosis on the Successful Identification of Multiple Sclerosis Subtypes
Fred Lublin, MD - Faculty Chair
Director, Corinne Goldsmith Dickinson Center for MS
Mount Sinai School of Medicine
New York, NY
- David M. Kaufman, MD - Course Director
Professor of Neurology and Psychiatry
Albert Einstein College of Medicine
Bronx, NY
Target Audience
Physicians specializing in the care of patients with multiple sclerosis.
Activity Goal
The goal of this activity is to provide better patient care by offering MS professionals a practical look at the current diagnostic criteria to enable them to better understand how MS and its subtypes are diagnosed and how responses to new MS therapies are being measured.
Learning Objectives
At the end of the meeting, the audience should be better able to: - Review the different clinical assessment scales and how they are used to stage multiple sclerosis (MS), monitor disease progression, and assess treatment efficacy
- Explain the radiological imaging technologies, including established technologies and technologies in development, used to assess disease activity and to monitor disease progression
- Describe the advances in clinical laboratory analyses, both serological and cerebrospinal fluid, which can be used to assess disease activity and to monitor disease progression
Accreditation Statement
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Albert Einstein College of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been planned and produced in accordance with the ACCME Essentials and Policies.
Sponsored by Albert Einstein College of Medicine & Montefiore Medical Center
 
Made possible by an educational grant from Genentech, Inc. and Biogen Idec
Developed by M2 Communications, Inc.
Click on this link to access the program http://www.m2usa.com/diagnosing_ms
|
|
